Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,956,310 Time indicator tampon
A tampon comprising an absorbent pledget and a time-lapse indicator associated therewith is provided. The time-lapse indicator includes a sensory material...
US-9,956,309 Technologies for sanitizing humidifiers
Technologies (e.g., devices, systems and methods) for sanitizing reservoirs of humidifiers are described. In some embodiments, the technologies include a...
US-9,956,308 Method and apparatus for disinfection of a temperature control device for human body temperature control during...
The present application relates to a method for disinfection of a temperature control device for human body temperature control during extracorporeal...
US-9,956,307 Methods and apparatus for treatment of luer connectors
Devices, methods, and systems for a luer connector treatment device are described herein. The luer connector treatment device may include one or multiple...
US-9,956,306 Room decontamination system, method and controller
A room decontamination systems, controllers and methods for decontaminating a room. The room decontamination system may be a UV room decontamination system that...
US-9,956,305 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer
A method of reducing radiation exposure of a non-cancerous tissue of a patient diagnosed with a cancer includes administering to the patient an agent capable of...
US-9,956,304 Contrast agents, methods for preparing contrast agents, and methods of imaging
Provided is a protein contrast agent for enhancing an MRI image and comprising a polypeptide having a conformation presenting at least five oxygen atoms...
US-9,956,303 Anti-met therapy for previously diagnosed cancer patients
The present invention relates to methods useful in the selection of cancer patients suitable for treatment with therapies directed at c-Met. The method employs...
US-9,956,302 Compounds and compositions for the treatment of ocular disorders
The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and...
US-9,956,301 Complex of garcinol, cyclodextrin and method thereof
The present disclosure discloses a pharmaceutical molecule of Garcinol chemically complexed with cyclodextrins and the use of the complexed molecule in...
US-9,956,300 Hydrogels formed from polypeptide micelles and methods of use thereof
The presently disclosed subject matter is directed to compositions, methods, and systems (e.g., platforms) comprising the same, the systems comprising,...
US-9,956,299 Pyrrolobenzodiazepine--antibody conjugates
Conjugates of specific PBD dimers with an antibody that binds to CD22, the antibody comprising a VH domain having the sequence according to SEQ ID NO. 1.
US-9,956,298 Pyrrolobenzodiazepines and conjugates thereof
A compound which is selected from A: and salts and solvates thereof. ##STR00001##
US-9,956,297 FAP-activated proteasome inhibitors for treating solid tumors
Disclosed are proteasome inhibitors, fibroblast activation protein (FAP)-activated prodrugs of proteasome inhibitors, and pharmaceutically acceptable salts of...
US-9,956,296 Compounds containing a vascular disrupting agent
The present invention relates to compounds, and pharmaceutically acceptable salts thereof, comprising a vascular disrupting agent (VDA) associated and a MMP...
US-9,956,295 Reversible pegylated drugs
Reversible pegylated drugs are provided by derivatization of free functional groups of the drug selected from amino, hydroxyl, mercapto, phosphate and/or...
US-9,956,294 Targeted sensitization of non-del(5q) malignant cells
Disclosed are molecules for treating non-del(5q) MDS that mimic allelic deficiency in del5q MDS to sensitize the malignant clones of patient without del(5q)....
US-9,956,293 Targeted therapeutics
The present invention provides pharmacological compounds including an effector moiety conjugated to a binding moiety that directs the effector moiety to a...
US-9,956,292 Anti-methanogenic compositions and uses thereof
The present invention relates to, in part, methods and compositions for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel...
US-9,956,291 Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
A composition and an associated method for hepatic targeted delivery of thyroid receptor beta1 (TR.beta.1) agonist to a liver of a subject. The composition...
US-9,956,290 Peptide systems and methods for metabolic conditions
The present invention generally relates to compositions and methods for topical or transdermal delivery, and treatment of metabolic conditions. In some cases,...
US-9,956,289 Emulsion compositions containing quaternary ammonium compounds
Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the...
US-9,956,288 Highly concentrated stable meloxicam solutions
Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an...
US-9,956,287 Stable glucagon formulations
Stabilized formulations containing a peptide, such as a glucagon, are described herein. The formulations are in the form of a solution or suspension, which...
US-9,956,286 Devices and methods and agent-assisted medical procedures
Various embodiments of bulking or cushioning agents or material and related medical devices and methods are disclosed. For example, a method of performing a...
US-9,956,285 Anti-viral compounds
Disclosed herein are compounds and related compositions for the treatment of viral infection, including RNA viral infection, and compounds that can modulate the...
US-9,956,284 Immunoadjuvant flagellin-based compounds and use thereof
The present invention relates to novel peptide compounds derived from flagellin originating from Salmonelle enterica that exhibit an in vivo immune adjuvant...
US-9,956,283 Mammalian milk osteopontin for enhancing immune responsiveness
The disclosed invention provides mammalian milk osteopontin and/or an active truncation or active peptide thereof for improving immune responsiveness to an...
US-9,956,282 Bacterial compositions and methods of use thereof for treatment of immune system disorders
Provided are compositions containing combinations of bacteria useful for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract,...
US-9,956,281 Inactivated virus compositions and methods of preparing such compositions
The present invention is directed at a composition comprising a live swine flu virus having an infectious component and a plurality of surface antigens in...
US-9,956,280 Functional influenza virus-like particles (VLPs)
Recombinant influenza virus proteins, including influenza capsomers, subviral particles, virus-like particles (VLP), VLP complexes, and/or any portions of...
US-9,956,279 Vaccine for PCV2 and mycoplasma
A premixed multivalent vaccine in ready-to-use form comprising PCV2 ORF2 capsid antigen and M. hyopneumoniae antigen that reduces or prevents PCV2 infection...
US-9,956,278 Multivalent meningococcal conjugates and methods for preparing conjugates
Disclosed herein are meningococcal immunogenic conjugates which can elicit immune responses against meningococcal polysaccharides (PS) from groups A, C, W-135,...
US-9,956,277 Bacillus based delivery system and methods of use
Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of...
US-9,956,276 Vaccines against antigens involved in therapy resistance and methods of using same
Methods of reducing the likelihood of a cancer or precancer developing resistance to a cancer therapeutic or prevention agent are provided herein. The methods...
US-9,956,275 Methods of inhibiting platelet aggregation and preventing thrombosis using antibodies that bind...
Methods of inhibiting platelet activation and aggregation using peptide vaccine or antibodies that have binding specificity for the .beta. subunit of the...
US-9,956,274 Method to generate antibodies to ion channels
The present invention provides a method for generating a functionally modifying antibody to an ion channel comprising immunizing a host with a cyclic peptide...
US-9,956,273 Compositions and methods for promoting neuronal outgrowth
Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate...
US-9,956,272 Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and...
Methods for preparing Factor X, activated Factor X, inactivated factor X and inactivated factor Xa, compositions comprising Factor X and Factor Xa, inactivated...
US-9,956,271 mRNA for use in treatment of human genetic diseases
Compositions for modulating the expression of a protein in a target cell comprising at least one RNA molecule which comprises at least one modification 5...
US-9,956,270 Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases...
The present invention relates to a pharmaceutical composition for treating or preventing a disease related to abnormal suppression of regulatory T cell activity...
US-9,956,268 Neuropeptide Y treatment of autoimmune disease
The present invention provides a method for treating or delaying the onset of an autoimmune condition in a human subject comprising orally administering to the...
US-9,956,267 Method of treating skeletal dysplasias using vessel dilator
C-natriuretic peptide (CNP) has been shown to regulate proliferation of mouse and rat osteoblasts. Genetic deletion of CNP results in dwarfism. CNP effects on...
US-9,956,266 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic...
US-9,956,265 Composition for aiding surgical procedures for treating ischemic vascular diseases
The present invention relates to a composition comprising erythropoietin (EPO) as an active ingredient for aiding surgical procedures for treating ischemic...
US-9,956,264 MIC-1 fusion proteins and uses thereof
The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog...
US-9,956,263 Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active...
Liposomal and/or nano-liposomal encapsulated HSP90a, HPf polypeptide (115 aa) and novel polypeptides HPf .DELTA.C1 (101 aa) and HPf.DELTA.C2 (87 aa), as well as...
US-9,956,262 Use of a bacterium isolated from the genus Pseudoalteromonas, cyclolipopeptides and uses thereof
The present invention relates to an isolated bacterium from the genus Pseudoalteromonas for its use as a probiotic, the use of said strain as a preservative,...
US-9,956,261 Methods of producing anamorelin hydrochloride having controlled chloride content
The present invention relates to particulate forms of anamorelin monohydrochloride or a composition comprising anamorelin monohydrochloride having controlled...
US-9,956,260 Treatment of HIV-1 infection and AIDS
Provided herein are compositions and methods for the treatment of a patient having an HIV-1 infection and/or AIDS. More specifically this invention provides...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.